By Day 12, the STAT3 decoy treated mice had a 2-fold reduction (p<0.05) in tumor volume compared to that of the no treatment control group and a 1.5-fold reduction (p<0.05) compared to that of STAT3-MB-mut + UTMC, respectively (Fig 3D). The gene discussed is STAT3; the disease is neoplasm.